From the recorded data, import of antibiotics to the UAE stood at 20.435 million USD in 2023. The forecasted values indicate a steady decline from 2024 to 2028:
- 2024: Import value predicted at 19.435 million USD
- 2025: Import value predicted at 18.97 million USD
- 2026: Import value predicted at 18.515 million USD
- 2027: Import value predicted at 18.068 million USD
- 2028: Import value predicted at 17.631 million USD
Year-on-year percentage variations:
- 2024: -4.89%
- 2025: -2.38%
- 2026: -2.42%
- 2027: -2.42%
- 2028: -2.42%
The Compound Annual Growth Rate (CAGR) from 2023 to 2028 is -2.93%, indicating a consistent decline in the import value of antibiotics over the forecasted period.
Future trends to watch for include potential shifts in local production capabilities, changes in healthcare policies, emergence of alternative treatments, and global supply chain dynamics which may impact the import dependency and overall demand for antibiotics in the UAE.
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
